Pyrimidine nucleotide carrier 1 in mitochondrial homeostasis and cancer

Show simple item record

dc.contributor.advisor O'Connor, Rosemary en
dc.contributor.author Coleman, Michael
dc.date.accessioned 2017-06-02T08:39:03Z
dc.date.issued 2017
dc.date.submitted 2017
dc.identifier.citation Coleman, M. F. 2017. Pyrimidine nucleotide carrier 1 in mitochondrial homeostasis and cancer. PhD Thesis, University College Cork. en
dc.identifier.uri http://hdl.handle.net/10468/4039
dc.description.abstract Abnormal metabolism has been a known feature of cancer for close to a decade, with mitochondrial dysfunction, aerobic glycolysis, and abnormal biosynthetic metabolism present in many cancers. Dysfunctional mitochondria alone have been shown to significantly influence cancer phenotype. Mitochondrial reprogramming has been demonstrated as an essential cancer cell survival response to diverse challenges. Our work has examined the significance of pyrimidine nucleotide carrier 1 (PNC1), an Insulin like Growth Factor 1 (IGF- 1)-inducible mitochondrial Uridine-5'-triphosphate (UTP) transporter in cancer. Loss of PNC1 is lethal, while suppression of PNC1 in cancer cells has been demonstrated to induce Epithelial to Mesenchymal Transition (EMT) driven by mitochondrial dysfunction and Reactive Oxygen Species (ROS). While PNC1 is ubiquitously expressed, PNC1 is frequently expressed at lower levels in solid tumours than in normal tissue. PNC1 can be suppressed by hypoxia, potentially through antagonism of MYC signalling. We also demonstrated that ectopic expression of PNC1 can revert the migratory phenotype of invasive MDA-MB-231 cells, and restore oxidative phosphorylation (OXPHOS) activity to these cells. These data suggest that the mitochondrial dysfunction present in these cells is partially due to their low PNC1 expression. Conversely, we observed that suppression of PNC1 in MCF-7 cells suppresses OXPHOS. Intriguingly, suppression of PNC1 impairs mitophagy in response to both mitochondrial depolarisation and hypoxia. We implicated disruption of the activity of the Nicotinamide adenine dinucleotide (NAD+) dependent deacetylase Sirtuin 1 (SIRT1) in this impairment of mitophagy/autophagy. Crucially we observed strong support for these key findings in human cancer, where PNC1 expression is inversely correlated with markers of hypoxia signalling, and positively correlated with OXPHOS and autophagy. Overall the conclusion is that suppression of PNC1 in cancer may promote mitochondrial dysfunction, and critically, permit the persistence of dysfunctional mitochondria due to impaired mitophagy. Thus, reduced PNC1 expression has the potential to influence cancer phenotype. en
dc.description.sponsorship Irish Cancer Society (CRS12COL) en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher University College Cork en
dc.rights © 2017, Michael Francis Coleman. en
dc.rights.uri http://creativecommons.org/licenses/by-nc-nd/3.0/ en
dc.subject Mitochondria en
dc.subject IGF-1 en
dc.subject PNC1 en
dc.subject SLC25A33 en
dc.subject Cancer en
dc.subject Breast en
dc.subject Mitophagy en
dc.subject Metabolism en
dc.title Pyrimidine nucleotide carrier 1 in mitochondrial homeostasis and cancer en
dc.type Doctoral thesis en
dc.type.qualificationlevel Doctoral en
dc.type.qualificationname PhD (Science) en
dc.internal.availability Full text not available en
dc.check.info Indefinite en
dc.check.date 10000-01-01
dc.description.version Accepted Version
dc.contributor.funder Irish Cancer Society en
dc.description.status Not peer reviewed en
dc.internal.school Biosciences Institute en
dc.check.reason This thesis is due for publication or the author is actively seeking to publish this material en
dc.check.opt-out Yes en
dc.thesis.opt-out true
dc.check.entireThesis Entire Thesis Restricted
dc.check.embargoformat E-thesis on CORA only en
dc.internal.conferring Summer 2017 en


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

© 2017, Michael Francis Coleman. Except where otherwise noted, this item's license is described as © 2017, Michael Francis Coleman.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement